
On Tuesday, the European Council reached an agreement on a proposal for a set of rules which will beef up the role of the European Medicines Agency (EMA) in crisis preparation and management for medicinal drugs and medical equipment, according to an EC press release.
"Although covid-19 is still taking its toll, we need to be better prepared for when another health crisis strikes. A stronger European Medicines Agency will play a key role in this. It will help us to prevent shortages of critical medicines and medical devices and be faster in developing medicines to fight any disease causing a crisis," states Portugal Minister for Health Marta Temido.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.